title: Dehydroepiandrosterone in relation to adiposity, glucose tolerance and lipid spectra in Czech non-diabetic population.
abstract: This study aimed to examine relationships between DHEA(S), anthropometric parameters, oral glucose tolerance test derived data and lipid spectra in a Czech non-diabetic population. 380 healthy volunteers both with and without a family history of diabetes type 2 (DM2) were enrolled into the study (women: n=235, age 28.9+/-9.4 years, BMI 22.3+/-4.5 kg/m(2), men: n=145, age 32.3+/-10.0 years, BMI 24.7+/-3.6 kg/m(2)). Spearman's correlations (both without and with the adjustment for age, age and BMI), as well as ANCOVA were used. Non-adjusted data showed many "beneficial" correlations between DHEA(S) and both anthropometric and metabolic variables. Statistical analysis revealed that almost all correlations of DHEA(S) to adiposity and fat distribution in men as well as in women disappeared after the adjustment. There are, however, differences between men and women in the correlation of DHEA(S) to insulin sensitivity and lipid levels. The use of hormonal contraceptives (COC) is also an important factor in this relationship. In men and also in women using COC, DHEA-S after adjustment correlated positively with fasting and stimulated glucose, insulin and C-peptide, and negatively with insulin sensitivity. In this respect, the benefit of DHEA(S) supplementation seems -- at least in terms of its alleged antiobesity and antidiabetogenic effects -- to be more than controversial.
authors.affiliation: Institute of Endocrinology, Prague, Czech Republic. bbendlova@endo.cz
authors.forename: B
authors.initials: B
authors.lastname: Bendlová
authors.forename: J
authors.initials: J
authors.lastname: Vrbíková
authors.forename: M
authors.initials: M
authors.lastname: Hill
authors.forename: M
authors.initials: M
authors.lastname: Vaňková
authors.forename: P
authors.initials: P
authors.lastname: Lukášová
authors.forename: J
authors.initials: J
authors.lastname: Včelák
authors.forename: D
authors.initials: D
authors.lastname: Vejražková
authors.forename: K
authors.initials: K
authors.lastname: Dvořáková
authors.forename: R
authors.initials: R
authors.lastname: Hampl
authors.forename: K
authors.initials: K
authors.lastname: Vondra
authors.forename: L
authors.initials: L
authors.lastname: Stárka
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism*; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D015992:Body Mass Index; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003271:Contraceptive Agents, Female / Q000627:therapeutic use; D018153:Czech Republic; D003687:Dehydroepiandrosterone / Q000097:blood*; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D018149:Glucose Intolerance / Q000378:metabolism*; D006801:Humans; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008055:Lipids / Q000097:blood*; D008297:Male; D012738:Sex Hormone-Binding Globulin / Q000378:metabolism
chemical_list: D001786:Blood Glucose; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D003271:Contraceptive Agents, Female; D005230:Fatty Acids, Nonesterified; D008055:Lipids; D012738:Sex Hormone-Binding Globulin; D003687:Dehydroepiandrosterone; D019314:Dehydroepiandrosterone Sulfate; D007334:Insulin-Like Growth Factor I